OTC Pharmaceuticals in Switzerland

Datamonitor, December 2010, Pages: 44

The OTC Pharmaceuticals in Switzerland industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

- Contains an executive summary and data on value, volume and/or segmentation

- Provides textual analysis of OTC Pharmaceuticals in Switzerland’s recent performance and future prospects

- Incorporates in-depth five forces competitive environment analysis and scorecards

- Includes a five-year forecast of OTC Pharmaceuticals in Switzerland

- The leading companies are profiled with supporting key financial metrics

- Supported by the key macroeconomic and demographic data affecting the market

Highlights

- Detailed information is included on market size, measured by both value and volume

- Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

- Market shares are covered by manufacturer and/or brand

- Also features market breakdown by distribution channel

Why you should buy this report

- Spot future trends and developments

- Inform your business decisions

- Add weight to presentations and marketing materials

- Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

EXECUTIVE SUMMARY
MARKET OVERVIEW
Market definition
Research highlights
Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SHARE
FIVE FORCES ANALYSIS
Summary
Buyer power
Supplier power
New entrants
Substitutes
Rivalry
LEADING COMPANIES
Johnson & Johnson
Novartis AG
Bayer AG
MARKET DISTRIBUTION
MARKET FORECASTS
Market value forecast
MACROECONOMIC INDICATORS
APPENDIX
Methodology
Industry associations
Related Datamonitor research
Disclaimer
ABOUT DATAMONITOR
Premium Reports
Summary Reports
Datamonitor consulting

LIST OF TABLES
Table 1: Switzerland OTC pharmaceuticals market value: $ million, 2005–09
Table 2: Switzerland OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 3: Switzerland OTC pharmaceuticals market share: % share, by value, 2009
Table 4: Johnson & Johnson: key facts
Table 5: Johnson & Johnson: key financials ($)
Table 6: Johnson & Johnson: key financial ratios
Table 7: Novartis AG: key facts
Table 8: Novartis AG: key financials ($)
Table 9: Novartis AG: key financial ratios
Table 10: Bayer AG: key facts
Table 11: Bayer AG: key financials ($)
Table 12: Bayer AG: key financials (€)
Table 13: Bayer AG: key financial ratios
Table 14: Switzerland OTC pharmaceuticals market distribution: % share, by value, 2009
Table 15: Switzerland OTC pharmaceuticals market value forecast: $ million, 2009–14
Table 16: Switzerland size of population (million), 2005–09
Table 17: Switzerland gdp (constant 2000 prices, $ billion), 2005–09
Table 18: Switzerland gdp (current prices, $ billion), 2005–09
Table 19: Switzerland inflation, 2005–09
Table 20: Switzerland consumer price index (absolute), 2005–09
Table 21: Switzerland exchange rate, 2005–09

LIST OF FIGURES
Figure 1: Switzerland OTC pharmaceuticals market value: $ million, 2005–09
Figure 2: Switzerland OTC pharmaceuticals market segmentation I:% share, by value, 2009
Figure 3: Switzerland OTC pharmaceuticals market share: % share, by value, 2009
Figure 4: Forces driving competition in the OTC pharmaceuticals market in Switzerland, 2009
Figure 5: Drivers of buyer power in the OTC pharmaceuticals market in Switzerland, 2009
Figure 6: Drivers of supplier power in the OTC pharmaceuticals market in Switzerland, 2009
Figure 7: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Switzerland, 2009
Figure 8: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Switzerland, 2009
Figure 9: Drivers of degree of rivalry in the OTC pharmaceuticals market in Switzerland, 2009
Figure 10: Johnson & Johnson: revenues & profitability
Figure 11: Johnson & Johnson: assets & liabilities
Figure 12: Novartis AG: revenues & profitability
Figure 13: Novartis AG: assets & liabilities
Figure 14: Bayer AG: revenues & profitability
Figure 15: Bayer AG: assets & liabilities
Figure 16: Switzerland OTC pharmaceuticals market distribution: % share, by value, 2009
Figure 17: Switzerland OTC pharmaceuticals market value forecast: $ million, 2009–14

Customers who bought this item also bought

• OTC Pharmaceuticals in Switzerland
• Healthcare, Regulatory and Reimbursement Landscape - Switzerland
• Switzerland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
• OTC Healthcare in Switzerland to 2014
• OTC Healthcare in Switzerland to 2013
• OTC Distribution in Europe: Entering a new Era - New Expanded 2012 Edition
• Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
• Other OTC Healthcare Products Market in Switzerland to 2014 (OTC Healthcare)
• OTC Pharmaceuticals in Europe
• OTC Pharmaceuticals - Scandinavia Industry Guide